This is among the first and largest summaries of the use of neoadjuvant PD-1 inhibitor (nivolumab) in patients with resectable lung cancer. The safety profile was adequate, 20 of 21 patients underwent complete resection, and the pathologic major response rate was 45%. The response was similar regardless of PD-L1 status, and response was related to
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Lung Cancer - Surgery
May 14, 2018
Thomas and colleagues performed a retrospective analysis of patient information from the National Surgical Quality Improvement Program database to identify risk factors for postdischarge venous thromboembolism (VTE) following lung resection.
May 11, 2018
Patient Care
May 4, 2018
Patient Care and General Interest
An article in the New York Times looks at the ethical dilemma of performing surgery for endocarditis in illicit drug users whose addictions go untreated.
April 13, 2018
The authors demonstrate that mediastinoscopy at the time of either open or VATS lobectomy is independently associated with an increased risk of postoperative pulmonary complications (OR 1.46 and 1.53, respectively).
April 13, 2018
The authors studied patients after resection of stage I non-small cell lung cancer. They found that nearly one-third had decreased muscle one year postoperatively, which was associated with poor performance status and decreased overall and cancer-specific survival.
March 9, 2018
Patient Care
Carter Capps, a pitcher for professional baseball team the San Diego Padres, has made himself a necklace out of the rib surgeons removed during his thoracic outlet surgery.
February 26, 2018
Weder and colleagues present a debate addressing surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer. Arguments relating to outcome and the impact on further therapy are given by both surgeons and radiation oncologists.
January 22, 2018
A model analysis of a phase I surgical device trial. The readable editorial discusses the adoption of surgical innovation on the occasion of a harmonic sealing device for pulmonary resections, highlighting the problem of ligating small branches of the pulmonary artery in confined spaces.
January 17, 2018
Find it here: The First International Conference on Sublobar Resections for Lung Cancer.